COPD Trial, Recruiting NCT06755008 Sponsor: University Hospital, Montpellier Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06755008
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older (male or female).
  • A lung specialist has determined you need a bronchoscopy (a procedure to look inside the airways) for a reason such as follow-up care, investigating a lung nodule, coughing up blood, persistent cough, mucus production, recurring bronchitis, or to help identify a condition.
  • (Group 1 – COPD patients) You are a current or former smoker with a significant smoking history (at least 10 pack-years) and have been diagnosed with COPD, confirmed by a breathing test within the past year.
  • (Group 2 – Smokers without COPD) You are a current or former smoker with a significant smoking history (at least 10 pack-years) but do not have any breathing obstruction, confirmed by a breathing test within the past year.
  • (Group 3 – Non-smoker controls) You have never smoked, or you quit smoking more than 10 years ago with a limited smoking history, and you do not have any breathing obstruction, confirmed by a breathing test within the past year.

Who may not be able to join:

  • You have widespread cancer or an advanced cancer diagnosis.
  • You have another ongoing or progressing lung condition, such as asthma, tuberculosis, scarring of the lungs, or a recent or active lung infection.
  • You currently use illegal drugs or consume alcohol to a significant extent (confirm with trial site).
  • You are currently in prison or detained by a legal or administrative order, or are under involuntary hospitalisation.
  • You are already taking part in another research study that has a waiting period before joining a new study.
  • You have recent or current serious mental health difficulties that prevent you from fully understanding and agreeing to participate, or that require urgent medical care.
  • You are an adult who is under a legal protection order, such as guardianship or curatorship.
  • You are not able to give your informed consent to take part.
  • You do not speak French and do not have a trusted person available to help you understand the study information.
  • You are not registered with or covered by a French social security (health insurance) system.
  • You are pregnant or currently breastfeeding.
  • You decline to give your consent after being fully informed about the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mathilde VOLPATO, MD, University Hospital, Montpellier

Phone: (0)467042020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 February 2025
Est. completion
1 January 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The main objective is to evaluate the repair capacity of the bronchial epithelium of COPD subjects using the reconstituted bronchial epithelium model in air/liquid interface culture and the iPS model.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov